Helix

Specialisation

Cornea

Full title

A double-masked study of SYL1001 in patients with moderate to dry eye disease (DED).

Promoter

Iris Pharma

Start date

June 2017

End date

April 2019

Researchers

Main: Ms. Laura Zahiño